Quality of life in users of non-steroidal anti-inflammatory drugs

Scandinavian Journal of Gastroenterology, Supplement

Volumn 31, Issue 221, 1996, Pages 23-24

  Hawkey, C J ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Dyspepsia; NSAID; QOL

Indexed keywords

MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ARTHRITIS; CONFERENCE PAPER; DIARRHEA; HEPATITIS; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; ARTICLE; CHEMICALLY INDUCED DISORDER; DYSPEPSIA; GASTROINTESTINAL DISEASE; RHEUMATOID ARTHRITIS; RISK;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DYSPEPSIA; GASTROINTESTINAL DISEASES; HUMANS; QUALITY OF LIFE; RISK;

EID: 0030442398     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609095548     Document Type: Conference Paper

References (12)

1. Hawkey CJ, Cullen DJE, Pearson G, Holmes S, Doherty M, Wilson JV, et al. Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham General Practices: Could ibuprofen be used more widely? Br Med J (unpublished observations).
2. Henry DA. Side effects of non-steroidal anti-inflammatory drugs. Bailliere's Clin Rheumatol 1988;2:425-54.
3. Ramey DR, Raynauld J-P, Fries JF. The Health Assessment Questionnaire 1992. Status and Review. Arthritis Care Res 1992;5(3):119-29.
4. Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittmawn RM, Geis GW. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Int Med 1995;123(4):241-9.
5. Cole AT, Hudson N, Liew LCW, May JA, Murray FE, Heptinstall S, Hawkey CJ. Low-dose aspirin: effects on platelet function, mucosal prostaglandin E2 and gastroduodenal mucosal injury. A placebo controlled comparison of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg (Nuseals) (unpublished observations).
6. Hudson N, Wilkinson MJ, Swannell AJ, Steele RJ, Hawkey CJ. Ileo-caecal ulceration associated with the use of diclofenac retard. Aliment Pharmacol Ther 1993;7:197-200.
7. Hawkey CJ. Trials in osteoarthritis. Br Med J 1995(letter); 310:666-7.
8. March L, Irwig L, Schwarz J, Simpson J, Chock C, Brooks P. Trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. Br Med J 1994;309:1041-5.
9. Stucki G, Stucki S, Bruhlmann P, Michel BA. Ceiling effects of the Health Assessment Questionnaire and its modified version in some ambulatory rheumatoid arthritis patients. Ann Rheum Dis 1995;54(6):461-5.
10. Hunt S, McKenna SP, McEwan J. The Nottingham Health Profile user's manual. Manchester Colon Research and Consultancy, 1989.
11. Dupuy HJ. The Psychological General Well-being (PGWB) Index. In: Wenger NK, Mattson ME, Furberg CD, Elinsson J, editors. Assessment of Quality of Life in clinical trials of cardiovascular therapies. Le Jacq Publishing Inc, 1984;170-83.
12. Svedlund J, Sjodin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-34.